Fernando Laguia

Barcelona, CT 08916, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: May 21, 2026

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Journal: JCI insight

Published: October 09, 2025

Massive endocytosis mechanisms are involved in uptake of HIV-1 particles by monocyte-derived dendritic cells.

Massive endocytosis mechanisms are involved in uptake of HIV-1 particles by monocyte-derived dendritic cells.

Journal: Frontiers in immunology

Published: October 03, 2024

Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.

Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.

Journal: Med (New York, N.Y.)

Published: March 13, 2024

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.

Journal: Frontiers in pharmacology

Published: November 01, 2023

Role of Siglecs in viral infections: A double-edged sword interaction.

Role of Siglecs in viral infections: A double-edged sword interaction.

Journal: Molecular aspects of medicine

Published: May 28, 2022

Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.

Journal: Frontiers in oncology

Published: June 04, 2020

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies.

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies.

Journal: Cancers

Published: April 17, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026